Tissue factor pathway inhibitor gene transfer prevents vascular smooth muscle cell proliferation by interfering with the MCP-3/CCR2 pathway

Laboratory Investigation

Volumn 95, Issue 11, 2015, Pages 1246-1257

  Fu, Yu ^a   Ma, Dandan ^a   Liu, Yue ^a   Li, Hui ^a   Chi, Jinyu ^a   Liu, Wenxiu ^a   Lin, Fang ^a   Hu, Jing ^b   Zhang, Xiaohui ^a   Zhu, Minling ^a   Zhao, Yong ^a   Yin, Xinhua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN KINASE B; SHORT HAIRPIN RNA; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; CCL7 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; TUMOR NECROSIS FACTOR;

ADENOVIRIDAE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE TRANSFER; IN VITRO STUDY; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL7; LIPOPROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, CCR2; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945930244     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.106     Document Type: Article

References (39)

1. Al-Bannawi A, Al-Wesebai K, Taha S et al. Chlamydia pneumoniae induces chemokine expression by platelets in patients with atherosclerosis. Med Princ Pract 2011;20:438-443.
2. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atheroscle-rosis: new perspectives and therapeutic strategies. Nat Med 2002;8:1249-1256.
3. Andres V, Pello OM, Silvestre-Roig C. Macrophage proliferation and apoptosis in atherosclerosis. Curr Opin Lipidol 2012;23:429-438.
4. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011;145:341-355.
5. Rosenfeld ME. Inflammation and atherosclerosis: direct versus indirect mechanisms. Curr Opin Pharmacol 2013;13:154-160.
6. Liu XL, Zhang PF, Ding SF et al. Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice. PLoS One 2012;7:e33497.
7. Tsou CL, Peters W, Si Y et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007;117:902-909.
8. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008;28:1950-1959.
9. An SJ, Jung UJ, Choi MS et al. Functions of monocyte chemotactic protein-3 in transgenic mice fed a high-fat, high-cholesterol diet. J Microbiol Biotechnol 2013; 23: 405-413.
10. Maddaluno M, Di Lauro M, Di Pascale A et al. Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation. Atherosclerosis 2011;217:113-119.
11. Lwaleed BA, Bass PS. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol 2006;208:327-339.
12. Kopp CW, Holzenbein T, Steiner S et al. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. Blood 2004;103:1653-1661.
13. Yin X, Yutani C, Ikeda Y et al. Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries. Cardiovasc Res 2002;56:454-463.
14. Yin X, Fu Y, Yutani C et al. HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteries. Int J Cardiol 2009;135:245-248.
15. Fu Y, Zhang Z, Zhang G et al. Adenovirus-mediated gene transfer of tissue factor pathway inhibitor induces apoptosis in vascular smooth muscle cells. Apoptosis 2008;13:634-640.
16. Fu Y, Zhao Y, Liu Y et al. Adenovirus-mediated tissue factor pathway inhibitor gene transfer induces apoptosis by blocking the phosphor-ylation of JAK-2/STAT-3 pathway in vascular smooth muscle cells. Cell Signal 2012;24:1909-1917.
17. Zhao Y, Fu Y, Hu J et al. The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IκB-α stimulated by tumour necrosis factor-α in cultured vascular smooth muscle cells. Arch Cardiovasc Dis 2013;106:4-11.
18. Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 2011;4:104-111.
19. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-2138.
20. Zhang S, Wang X, Zhang L et al. Characterization of monocyte chemoattractant proteins and CC chemokine receptor 2 expression during atherogenesis in apolipoprotein E-null mice. J Atheroscler Thromb 2011;18:846-856.
21. Chan CT, Moore JP, Budzyn K et al. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorti-costerone/salt-treated mice. Hypertension 2012;60:1207-1212.
22. Aukrust P, Halvorsen B, Yndestad A et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008;28:1909-1919.
23. Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010;411:1570-1579.
24. Ali ZA, Bursill CA, Douglas G et al. CCR2-mediated antiinflammatory effects of endothelial tetrahydrobiopterin inhibit vascular injury-induced accelerated atherosclerosis. Circulation 2008;118:S71-S77.
25. Wang X, Li X, Yue TL et al. Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty. Biochim Biophys Acta 2000;1500: 41-48.
26. Lötzer K, Döpping S, Connert S et al. Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling. Arterioscler Thromb Vasc Biol 2010;30:395-402.
27. Kamikubo Y, Nakahara Y, Takemoto S et al. Human recombinant tissue factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells. FEBS Lett 1997;407:116-120.
28. Sato Y, Asada Y, Marutsuka K et al. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Haemost 1997;78:1138-1141.
29. Atsuchi N, Nishida T, Marutsuka K et al. Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries. Circulation 2001;103:570-575.
30. Nakamura Y, Nakamura K, Ohta K et al. Anti-inflammatory effects of long-lasting locally-delivered human recombinant tissue factor pathway inhibitor after balloon angioplasty. Basic Res Cardiol 2002;97:198-205.
31. Fenyo IM, Gafencu AV. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis. Immunobiology 2013;218:1376-1384.
32. Grassia G, Maddaluno M, Guglielmotti A et al. The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice. Cardiovasc Res 2009;84:485-493.
33. Horvath C, Welt FGP, Nedelman M et al. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates. Inhibitory potential depends on type of injury and leukocytes targeted. Circ Res 2002;90:488-494.
34. Boring L, Gosling J, Cleary M et al. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-897.
35. Bousquenaud M, Schwartz C, Léonard F et al. Monocyte chemotactic protein 3 is a homing factor for circulating angiogenic cells. Cardiovasc Res 2012;94:519-525.
36. Boring L, Gosling J, Chensue SW et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-2261.
37. Jia T, Serbina NV, Brandl K et al. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during listeria monocytogenes infection. J Immunol 2008;180:6846-6853.
38. Shahrara S, Amin MA, Woods JM et al. Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis. Arthritis Rheum 2003;48:3568-3583.
39. Peppel K, Zhang L, Orman ES et al. Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovasc Res 2005;65:674-682.